COLL vs JPM · P/E 17, rev $181.9M vs P/E 14, rev $182.45B
Collegium Pharmaceutical Inc (COLL) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported JPM revenue for 2025-12-31 was $182.45B. Net income was $57.05B. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the COLL and JPM stock pages for the full models.
Not investment advice.